Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Perrigo, Cobrek get FDA nod for generic Luxiq foam
Perrigo and Cobrek Pharmaceuticals received regulatory approval for the 0.12% formulation of betamethasone validate foam to address scalp psoriasis. The treatment is the generic version of Stiefel Labs' Luxiq foam.
Drug Store News (11/28)
Or we can send an email on your behalf